JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 11, 2005; DOI: 10.1124/jpet.105.084459


0022-3565/05/3133-983-994$20.00
JPET 313:983-994, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.084459v1
313/3/983    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, G. M.
Right arrow Articles by Madras, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, G. M.
Right arrow Articles by Madras, B. K.

NEUROPHARMACOLOGY

Primate Trace Amine Receptor 1 Modulation by the Dopamine Transporter

Gregory M. Miller, Christopher D. Verrico, Amy Jassen, Martha Konar, Hong Yang, Helen Panas, Mary Bahn, Ryan Johnson, and Bertha K. Madras

Division of Neurochemistry, New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts

Recently identified trace amine receptors are potential direct targets for drugs of abuse, including amphetamine and 3,4-methylenedioxymethamphetamine (MDMA). We cloned full-length rhesus monkey trace amine receptor 1 (rhTA1) that was 96% homologous to human TA1. The trace amines tyramine and {beta}-phenylethylamine (PEA) and the monoamine transporter substrates (±)-amphetamine and (±)-MDMA stimulated cAMP accumulation in rhTA1-expressing cell lines, as measured by a cAMP response element-luciferase assay. Cocaine did not stimulate cAMP accumulation in rhTA1 cells, but it blocked [3H]PEA transport mediated by the dopamine transporter. Cotransfection with the human dopamine transporter enhanced PEA-, amphetamine-, and MDMA-mediated rhTA1 receptor activation, but it diminished tyramine activation of rhTA1. Because TA1 (EGFP-rhTA1 chimera) was largely intracellular, conceivably the dopamine transporter can facilitate access of specific agonists to intracellular TA1. rhTA1 mRNA expression was detected in rhesus monkey substantia nigra, implying that TA1 may be colocalized with the dopamine transporter in dopamine neurons. In summary, primate TA1 receptors are direct targets of trace amines, amphetamine, and MDMA. These receptors could also be indirect targets of amphetamine, MDMA, and cocaine through modification of monoamine transporter function. Conceivably, rhTA1 receptors may be located on pre- or postsynaptic membranes. Interference with the carrier function of monoamine transporters with a consequent rise of extracellular levels of trace amines could activate these receptors. The cloning of a highly homologous TA1 from rhesus monkey and demonstration that rhTA1 receptors are activated by drugs of abuse, indicate that nonhuman primates may serve to model physiological and pharmacological TA1-mediated responses in humans.


Received February 3, 2005; accepted March 8, 2005.

Address correspondence to: Dr. Bertha K. Madras, Department of Psychiatry, New England Primate Research Center, Harvard Medical School, One Pine Hill Dr., Southborough, MA 01772. E-mail: bertha_madras{at}hms.harvard.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
Z. Xie and G. M. Miller
A Receptor Mechanism for Methamphetamine Action in Dopamine Transporter Regulation in Brain
J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 316 - 325.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. J. Maguire, W. A. E. Parker, S. M. Foord, T. I. Bonner, R. R. Neubig, and A. P. Davenport
International Union of Pharmacology. LXXII. Recommendations for Trace Amine Receptor Nomenclature
Pharmacol. Rev., March 1, 2009; 61(1): 1 - 8.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. S. Barak, A. Salahpour, X. Zhang, B. Masri, T. D. Sotnikova, A. J. Ramsey, J. D. Violin, R. J. Lefkowitz, M. G. Caron, and R. R. Gainetdinov
Pharmacological Characterization of Membrane-Expressed Human Trace Amine-Associated Receptor 1 (TAAR1) by a Bioluminescence Resonance Energy Transfer cAMP Biosensor
Mol. Pharmacol., September 1, 2008; 74(3): 585 - 594.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z. Xie and G. M. Miller
{beta}-Phenylethylamine Alters Monoamine Transporter Function via Trace Amine-Associated Receptor 1: Implication for Modulatory Roles of Trace Amines in Brain
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 617 - 628.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z. Xie, S. V. Westmoreland, and G. M. Miller
Modulation of Monoamine Transporters by Common Biogenic Amines via Trace Amine-Associated Receptor 1 and Monoamine Autoreceptors in Human Embryonic Kidney 293 Cells and Brain Synaptosomes
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 629 - 640.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
C. D Verrico, L. Lynch, M. A Fahey, A.-K. Fryer, G. M Miller, and B. K Madras
MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor
J Psychopharmacol, March 1, 2008; 22(2): 187 - 202.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. A. Reese, J. R. Bunzow, S. Arttamangkul, M. S. Sonders, and D. K. Grandy
Trace Amine-Associated Receptor 1 Displays Species-Dependent Stereoselectivity for Isomers of Methamphetamine, Amphetamine, and Para-Hydroxyamphetamine
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 178 - 186.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z. Xie, S. V. Westmoreland, M. E. Bahn, G.-L. Chen, H. Yang, E. J. Vallender, W.-D. Yao, B. K. Madras, and G. M. Miller
Rhesus Monkey Trace Amine-Associated Receptor 1 Signaling: Enhancement by Monoamine Transporters and Attenuation by the D2 Autoreceptor in Vitro
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 116 - 127.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z. Xie and G. M. Miller
Trace Amine-Associated Receptor 1 Is a Modulator of the Dopamine Transporter
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 128 - 136.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. K. Madras, Z. Xie, Z. Lin, A. Jassen, H. Panas, L. Lynch, R. Johnson, E. Livni, T. J. Spencer, A. A. Bonab, et al.
Modafinil Occupies Dopamine and Norepinephrine Transporters in Vivo and Modulates the Transporters and Trace Amine Activity in Vitro
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 561 - 569.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
H. A. Navarro, B. P. Gilmour, and A. H. Lewin
A Rapid Functional Assay for the Human Trace Amine-Associated Receptor 1 Based on the Mobilization of Internal Calcium
J Biomol Screen, September 1, 2006; 11(6): 688 - 693.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.